Feldman and Pike's Vitamin D

51. Defining thresholds for vitamin D I: scientific rationale for serum 25-hydroxyvitamin D cutoffs of 25 and 50 nmol/L;
52. Defining thresholds for vitamin D II;
53. Methods of evaluating population studies of vitamin D: strengths and weaknesses;
54. Worldwide vitamin D status;
55. Vitamin D in fooddCompounds, stability, sources;
56. Determinants of vitamin D levels from sun exposure: a global perspective;
57. Vitamin D supplement use as a public health strategy to augment diet and sustain population adequacy;
58. Vitamin D and food fortification;
59. Bariatric surgery, vitamin D, and bone loss;
60. Genetic determinants of 25-hydroxyvitamin D concentrations;
61. Effect of vitamin D on health and disease: evidence from Mendelian randomization;
62. Growth plate histology, bone histomorphometry, and radiologic features of nutritional rickets and osteomalacia;
63. Vitamin D deficiency and nutritional rickets in infants and children;
64. Clinical disorders of phosphate homeostasis;
65. The hypocalcemic disorders;
66. Vitamin D hydroxylationedeficient rickets, type 1A;
67. The role of genetic variation in CYP2R1, the principal vitamin D 25- hydroxylase, and CYP3A4 in vitamin D homeostasis;
68. Hereditary 1,25-dihydroxyvitamin D resistant rickets (VDDR-2A);
69. Infantile hypercalcemia and CYP24A1 mutations;
70. Vitamin D and osteoporosis;
71. Adult vitamin D deficiencydfracture and fall prevention: findings from randomized controlled trials;
72. Randomized clinical trials of vitamin D and bone health;
73. Calcifediol as a therapeutic;
74. Vitamin D and organ transplantation;
75. Vitamin D, obesity, the metabolic syndrome and its sequelae;
76. The role of vitamin D in type 2 diabetes;
77. Liver metabolism and disease;
78. Vitamin D, hypertension, and cardiovascular disease;
79. Vitamin D and renal disease;
80. Vitamin D and kidney stones;
81. Hypercalcemia due to vitamin D toxicity;
82. Vitamin D and Paget's disease;
83. Vitamin D metabolism and disorders in companion animals;
84. Overview of vitamin D actions in cancer;
85. Vitamin D status and cancer incidence, mortality, and prognosis;
86. Antiproliferative and immunoregulatory actions of vitamin D derivatives on hematological malignancies: control of differentiation, proliferation, and cell death;
87. Vitamin D, inflammation, and cancer;
88. Vitamin D actions in mammary gland and breast cancer;
89. Vitamin D and colorectal cancer;
90. Vitamin D in the management of lung cancer: influence of tumor stage, tumor genotype, and treatment modality;
91. Vitamin D and prostate cancer;
92. Vitamin D and pancreatic cancer;
93. Sunlight, skin cancer and vitamin D;
94 . Vitamin D and antibacterial immunity;
95. Vitamin D and antiviral immunity;
96. Vitamin D and adaptive immunity in health and disease;
97. Vitamin D, microbiota, and inflammatory bowel disease;
98. Vitamin D and tuberculosis;
99. The role of vitamin D in COVID-19;
100 . Vitamin D and type 1 diabetes;
101. Vitamin D mechanisms of protection in multiple sclerosis;
102. Vitamin D and the epidemiology of multiple sclerosis;
103. Vitamin D and rheumatoid arthritis;
104. Psoriasis and other skin disorders;
105. Vitamin D, acute respiratory infection, and Asthma/COPD;
106. Vitamin D and acute illness;
Index for Volume 2

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Ortopedia e fracturas
• Medicina músculo-esquelética, motricidade

Vitamin D; vitamin D receptor; vitamin D metabolism; vitamin D deficiency; 25-hydroxyvitamin D3; 1,25-Dihydroxyvitamin D; 1a-Hydroxylase; vitamin D photobiology; biochemistry; bone homeostasis; bone health; osteocytes; phosphate absorption; parathyroid; adipose tissue; skeletal muscle; reproductive dysfunction